Fong Bryant 4
4 · Neos Therapeutics, Inc. · Filed Jun 17, 2019
Insider Transaction Report
Form 4
Fong Bryant
Director
Transactions
- Award
Stock Option (Right to Buy)
2019-06-13+46,907→ 46,907 totalExercise: $1.44Exp: 2029-06-13→ Common Stock (46,907 underlying)
Footnotes (1)
- [F1]This stock option vests in equal quarterly installments over a one-year period which began on June 13, 2019.